| Kaleigh Erin Hale Almeida, DO | |
|
255 Enterprise Blvd Ste 101, Greenville, SC 29615-3530 | |
| (864) 454-8120 | |
| (864) 454-8125 |
| Full Name | Kaleigh Erin Hale Almeida |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | 255 Enterprise Blvd Ste 101, Greenville, South Carolina |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073134862 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 90113 (South Carolina) | Primary |
| Entity Name | Prisma Health University Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295763217 PECOS PAC ID: 8325950983 Enrollment ID: O20031103000238 |
News Archive
Vaxonco Inc., a Korean company specializing in peptide-based vaccines and Ichor Medical Systems (Ichor), whose advanced TriGrid™ Delivery System (TriGrid™) is being tested worldwide for its ability to enhance delivery of DNA drugs and vaccines, announced today the initiation of a Phase I clinical trial to evaluate a novel DNA-based polyepitope vaccine against malaria.
Isis Pharmaceuticals, Inc. today announced its 2009 financial results and reviewed the highlights of the year. Isis achieved its 2009 financial guidance with pro forma net income of $166.9 million and a pro forma net operating loss (NOL) of $14.2 million compared with its guidance for the year of pro forma net income of more than $145 million and a pro forma NOL in the low to mid $20 million range. Isis also achieved its cash guidance by ending 2009 with $574.3 million of cash, cash equivalents and short-term investments significantly in excess of the $550 million projected.
Ikaria, Inc. announced that it has enrolled the first patients in its pivotal Phase III trial for LUCASSIN® (terlipressin). The multi-center, randomized, placebo-controlled, double-blind trial is known as the REVERSE Trial.
Antimicrobial reusable coffee cups are safer to use than ordinary plastic reusable cups, according to independent research undertaken by microbiologists at Aston University in Birmingham.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kaleigh Erin Hale Almeida, DO 300 E Mcbee Ave Fl 4, Greenville, SC 29601-2842 Ph: (864) 522-8603 | Kaleigh Erin Hale Almeida, DO 255 Enterprise Blvd Ste 101, Greenville, SC 29615-3530 Ph: (864) 454-8120 |
News Archive
Vaxonco Inc., a Korean company specializing in peptide-based vaccines and Ichor Medical Systems (Ichor), whose advanced TriGrid™ Delivery System (TriGrid™) is being tested worldwide for its ability to enhance delivery of DNA drugs and vaccines, announced today the initiation of a Phase I clinical trial to evaluate a novel DNA-based polyepitope vaccine against malaria.
Isis Pharmaceuticals, Inc. today announced its 2009 financial results and reviewed the highlights of the year. Isis achieved its 2009 financial guidance with pro forma net income of $166.9 million and a pro forma net operating loss (NOL) of $14.2 million compared with its guidance for the year of pro forma net income of more than $145 million and a pro forma NOL in the low to mid $20 million range. Isis also achieved its cash guidance by ending 2009 with $574.3 million of cash, cash equivalents and short-term investments significantly in excess of the $550 million projected.
Ikaria, Inc. announced that it has enrolled the first patients in its pivotal Phase III trial for LUCASSIN® (terlipressin). The multi-center, randomized, placebo-controlled, double-blind trial is known as the REVERSE Trial.
Antimicrobial reusable coffee cups are safer to use than ordinary plastic reusable cups, according to independent research undertaken by microbiologists at Aston University in Birmingham.
› Verified 9 days ago
David Markus Diamant, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 877 W Faris Rd Ste B, Greenville, SC 29605 Phone: 864-522-6225 Fax: 864-522-6235 | |
Michael James Poinsette, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 25 Creekview Ct, Greenville, SC 29615 Phone: 864-522-6300 Fax: 864-522-6305 | |
Steven M Newman, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 50 Cross Park Ct, Greenville, SC 29605 Phone: 864-271-9773 Fax: 864-271-1151 | |
Dr. Fariha Batool Sultan, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 255 Enterprise Blvd Ste 101, Greenville, SC 29615 Phone: 864-454-8120 Fax: 864-454-8125 | |
Jamie C Goodman, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6119 White Horse Rd Ste 14, Greenville, SC 29611 Phone: 864-614-7001 | |
Laura Colleen Nall, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 11402 Anderson Rd, Suite A, Greenville, SC 29611 Phone: 864-631-2799 Fax: 864-631-2795 | |
Allan Lee Gilmer, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1025 Verdae Blvd Ste A, Greenville, SC 29607 Phone: 864-242-4683 Fax: 864-248-8104 |